Progressive Cognitive Impairment and its Neuropathologic Correlates

$210.00

Gediminas Peter Gliebus, MD (Editor)
Drexel Neurosciences Institute, Drexel University College of Medicine, Philadelphia, PA, USA

Series: Neurodegenerative Diseases – Laboratory and Clinical Research
BISAC: SCI057000

The field of cognitive and behavioral neurology is rapidly changing. Almost daily discoveries deepen our understanding of various conditions affecting our cognitive function. Cognitive and behavioral neurology is becoming a very important integral part of the neurosciences.

The amount of already available and newly discovered information is growing, and the management of it might sometimes seem overwhelming to healthcare providers and to those in training. It is paramount to gain solid knowledge in order to critically navigate through new discoveries.

This book begins with an introduction to neuropathology of the most commonly encountered neurodegenerative conditions. The following chapter describes imaging biological marker studies of conditions such as Alzheimer’s disease and Lewy body spectrum disorders. Further chapters describe the function and dysfunction of different cognitive domains.

This book provides guidance to clinicians on how to approach progressive conditions in the clinic by evaluating cognitive domains affected, and understand which underlying pathology is more likely to cause it. That is the way practicing physicians approach it daily.
Neurology and psychiatry residents, fellows, medical students and already practicing healthcare providers should find this book useful as an introduction to this exciting field of neurology. (Imprint: Nova Biomedical)

Clear

Description

Table of Contents

Preface

Foreword
Carol F. Lippa (Drexel Neurosciences Institute, Drexel University College of Medicine, Philadelphia, PA, USA)

Introduction
Gediminas Peter Gliebus (Drexel Neurosciences Institute, Drexel University College of Medicine, Philadelphia, PA, USA)

Chapter 1. Neuropathology of Neurodegenerative Disorders
Esther N. Bit-Ivan and Eileen H. Bigio (Department of Pathology, Southern Illinois University School of Medicine, Springfield, IL, USA, and others)

Chapter 2. Imaging and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Lewy Body Spectrum Disorders
Usman Saeed, Sandra E. Black and Mario Masellis (Institute of Medical Science, University of Toronto Faculty of Medicine, Toronto, ON, Canada, and others)

Chapter 3. Function and Dysfunction of the Prefrontal Lobes in Neurodegenerative Diseases
Alexandre Henri-Bhargava, Donald T. Stuss and Morris Freedman (University of British Columbia (Island Medical Program), Victoria, B.C., Canada, and others)

Chapter 4. Action-Intentional Disorders in Neurodegenerative Diseases
Kenneth M. Heilman, Arash Salardini and Adam D. Falchook (Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA)

Chapter 5. Emotional Processing and Neurodegenerative Diseases
Peter Pressman and Elliott Ross (Department of Neurology, University of California San Francisco School of Medicine, San Francisco, CA, USA, and others)

Chapter 6. Memory disorders in Neurodegenerative Diseases
Gediminas Peter Gliebus (Drexel Neurosciences Institute, Drexel University College of Medicine, Philadelphia, PA, USA)

Chapter 7. Language Disorders in Neurodegenerative Diseases
Borna Bonakdarpour (Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA)

Chapter 8. Neurovisual Impairment in Neurodegenerative Diseases
Christian Schenk, Alan J. Lerner and Jill M. Farmer (Department of Neurology, University of Puerto Rico School of Medicine, San Juan, PR, and others)

Chapter 9. Introduction to Combined Cognitive and Movement Disorders
Jill M. Farmer (Drexel Neurosciences Institute, Drexel University College of Medicine, Philadelphia, PA, USA)

Index

Additional information

Binding

,